| Product Code: ETC13167612 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Pharmacovigilance Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Pharmacovigilance Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Pharmacovigilance Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Pharmacovigilance Market - Industry Life Cycle |
3.4 Europe Pharmacovigilance Market - Porter's Five Forces |
3.5 Europe Pharmacovigilance Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Pharmacovigilance Market Revenues & Volume Share, By Clinical Trial Phase, 2021 & 2031F |
3.7 Europe Pharmacovigilance Market Revenues & Volume Share, By Service Provider, 2021 & 2031F |
3.8 Europe Pharmacovigilance Market Revenues & Volume Share, By Type of Reporting, 2021 & 2031F |
3.9 Europe Pharmacovigilance Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Europe Pharmacovigilance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Pharmacovigilance Market Trends |
6 Europe Pharmacovigilance Market, 2021 - 2031 |
6.1 Europe Pharmacovigilance Market, Revenues & Volume, By Clinical Trial Phase, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Pharmacovigilance Market, Revenues & Volume, By Preclinical, 2021 - 2031 |
6.1.3 Europe Pharmacovigilance Market, Revenues & Volume, By Phase I, 2021 - 2031 |
6.1.4 Europe Pharmacovigilance Market, Revenues & Volume, By Phase II, 2021 - 2031 |
6.1.5 Europe Pharmacovigilance Market, Revenues & Volume, By Phase III, 2021 - 2031 |
6.1.6 Europe Pharmacovigilance Market, Revenues & Volume, By Phase IV, 2021 - 2031 |
6.2 Europe Pharmacovigilance Market, Revenues & Volume, By Service Provider, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Pharmacovigilance Market, Revenues & Volume, By In-house, 2021 - 2031 |
6.2.3 Europe Pharmacovigilance Market, Revenues & Volume, By Contract Outsourcing, 2021 - 2031 |
6.3 Europe Pharmacovigilance Market, Revenues & Volume, By Type of Reporting, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Pharmacovigilance Market, Revenues & Volume, By Spontaneous Reporting, 2021 - 2031 |
6.3.3 Europe Pharmacovigilance Market, Revenues & Volume, By Intensified ADR Reporting, 2021 - 2031 |
6.3.4 Europe Pharmacovigilance Market, Revenues & Volume, By Targeted Spontaneous Reporting, 2021 - 2031 |
6.3.5 Europe Pharmacovigilance Market, Revenues & Volume, By Cohort Event Monitoring, 2021 - 2031 |
6.3.6 Europe Pharmacovigilance Market, Revenues & Volume, By EHR Mining, 2021 - 2031 |
6.4 Europe Pharmacovigilance Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Pharmacovigilance Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Europe Pharmacovigilance Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.4.4 Europe Pharmacovigilance Market, Revenues & Volume, By Other End Users, 2021 - 2031 |
7 Europe Pharmacovigilance Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Pharmacovigilance Market, Revenues & Volume, By Clinical Trial Phase, 2021 - 2031 |
7.2.1 United Kingdom (UK) Pharmacovigilance Market, Revenues & Volume, By Clinical Trial Phase, 2021 - 2031 |
7.2.2 Germany Pharmacovigilance Market, Revenues & Volume, By Clinical Trial Phase, 2021 - 2031 |
7.2.3 France Pharmacovigilance Market, Revenues & Volume, By Clinical Trial Phase, 2021 - 2031 |
7.2.4 Poland Pharmacovigilance Market, Revenues & Volume, By Clinical Trial Phase, 2021 - 2031 |
7.2.5 Spain Pharmacovigilance Market, Revenues & Volume, By Clinical Trial Phase, 2021 - 2031 |
7.2.6 Rest of Europe Pharmacovigilance Market, Revenues & Volume, By Clinical Trial Phase, 2021 - 2031 |
7.3 Europe Pharmacovigilance Market Revenues & Volume Share, By Service Provider, 2021 & 2031F |
7.3.1 United Kingdom (UK) Pharmacovigilance Market, Revenues & Volume, By Service Provider, 2021 - 2031 |
7.3.2 Germany Pharmacovigilance Market, Revenues & Volume, By Service Provider, 2021 - 2031 |
7.3.3 France Pharmacovigilance Market, Revenues & Volume, By Service Provider, 2021 - 2031 |
7.3.4 Poland Pharmacovigilance Market, Revenues & Volume, By Service Provider, 2021 - 2031 |
7.3.5 Spain Pharmacovigilance Market, Revenues & Volume, By Service Provider, 2021 - 2031 |
7.3.6 Rest of Europe Pharmacovigilance Market, Revenues & Volume, By Service Provider, 2021 - 2031 |
7.4 Europe Pharmacovigilance Market, Revenues & Volume, By Type of Reporting, 2021 - 2031 |
7.4.1 United Kingdom (UK) Pharmacovigilance Market, Revenues & Volume, By Type of Reporting, 2021 - 2031 |
7.4.2 Germany Pharmacovigilance Market, Revenues & Volume, By Type of Reporting, 2021 - 2031 |
7.4.3 France Pharmacovigilance Market, Revenues & Volume, By Type of Reporting, 2021 - 2031 |
7.4.4 Poland Pharmacovigilance Market, Revenues & Volume, By Type of Reporting, 2021 - 2031 |
7.4.5 Spain Pharmacovigilance Market, Revenues & Volume, By Type of Reporting, 2021 - 2031 |
7.4.6 Rest of Europe Pharmacovigilance Market, Revenues & Volume, By Type of Reporting, 2021 - 2031 |
7.5 Europe Pharmacovigilance Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United Kingdom (UK) Pharmacovigilance Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Germany Pharmacovigilance Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 France Pharmacovigilance Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.4 Poland Pharmacovigilance Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.5 Spain Pharmacovigilance Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.6 Rest of Europe Pharmacovigilance Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Europe Pharmacovigilance Market Key Performance Indicators |
9 Europe Pharmacovigilance Market - Export/Import By Countries Assessment |
10 Europe Pharmacovigilance Market - Opportunity Assessment |
10.1 Europe Pharmacovigilance Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Pharmacovigilance Market Opportunity Assessment, By Clinical Trial Phase, 2021 & 2031F |
10.3 Europe Pharmacovigilance Market Opportunity Assessment, By Service Provider, 2021 & 2031F |
10.4 Europe Pharmacovigilance Market Opportunity Assessment, By Type of Reporting, 2021 & 2031F |
10.5 Europe Pharmacovigilance Market Opportunity Assessment, By End User, 2021 & 2031F |
11 Europe Pharmacovigilance Market - Competitive Landscape |
11.1 Europe Pharmacovigilance Market Revenue Share, By Companies, 2022 |
11.2 Europe Pharmacovigilance Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |